Hawkins, Inc. filings document formal disclosures for a Minnesota operating company in water treatment and specialty ingredients. Its recent 8-K filings include quarterly results furnished under Item 2.02, Regulation FD materials presenting historical financial information aligned to reporting segments, and shareholder voting results from the annual meeting.
The filing record covers the company’s Water Treatment, Food & Health Sciences, and Industrial Solutions segment framework, along with governance matters such as director elections, auditor ratification, and advisory executive compensation votes. These documents also provide the official record for material-event reporting, financial communications, and changes in how Hawkins presents its operating segments.
Hawkins, Inc. (HWKN) reported second-quarter fiscal 2027 sales of $313.8 million, up 12% from $280.4 million a year earlier, and net income of $27.8 million versus $22.6 million. Sales growth included 11% organic growth and approximately $3.7 million from acquired businesses; each of the three segments grew sales by at least 5%.
For the six months ended September 27, 2026, sales were $629.5 million versus $573.7 million and net income was $56.0 million versus $51.8 million. Gross profit was $150.6 million versus $140.0 million; a $3.9 million increase in the LIFO reserve reduced gross profit, partly offset by $1.3 million in refunds of previously paid tariffs.
Operating cash flow was $75.5 million, compared with $71.0 million. Hawkins repurchased 132,577 shares for $18.6 million during the six months; 598,967 shares remained available at September 27, 2026. Long-term debt was $229.0 million at September 27, 2026, versus $244.0 million at March 29, 2026. After quarter-end, Hawkins acquired substantially all assets of Eagle Labs on September 29, 2026, for approximately $14.0 million.
Hawkins, Inc. reported record fiscal 2027 second-quarter revenue of $313.8 million, up 12% from the prior-year quarter. Net income increased 23% to $27.8 million, diluted EPS rose 23% to $1.34, and adjusted EBITDA, a non-GAAP measure, increased 16% to $59.1 million. Revenue grew in all three segments: Water Treatment 16%, Food & Health Sciences 5%, and Industrial Solutions 10%. Gross profit rose 13% to $76.6 million; higher raw-material costs and fuel costs not fully recovered through freight charges pressured results.
For the six months ended September 27, 2026, operating cash flow was $75.5 million and free cash flow was $53.1 million, up 14%. Hawkins said free cash flow was allocated to $18.6 million of stock repurchases, $15.0 million of debt paydown, and $8.1 million of dividends. Quarter-end debt was $229.0 million, with leverage at 1.22x trailing-twelve-month adjusted EBITDA. Hawkins completed its acquisition of Dave Symonds & Associates, Inc. during the quarter and acquired Eagle Labs, Inc. after quarter-end, adding two Dallas–Fort Worth locations. Management expects second-half trends to be consistent with the first half; a $6.2 million second-half fiscal 2026 SG&A reduction was nonrecurring and will not recur in second-half fiscal 2027.
HAWKINS INC (HWKN) executive vice president and CFO Jeffrey P. Oldenkamp reported an open-market purchase of 1,290 shares of common stock on August 27, 2026 at $119.00 per share. After this transaction, he held 104,223.101 shares directly, including shares acquired through the dividend reinvestment and employee stock purchase plans, and 1,561.4324 shares indirectly through an ESOP trustee.
HAWKINS INC (HWKN) reported an open-market purchase of its common stock by insider Douglas A. Lange, VP - Water Treatment Group. On August 25, 2026, Lange purchased 910 shares at a weighted average price of $118.7536 per share, with individual trade prices ranging from $118.61 to $118.84 per share. Following this transaction, he directly owned 28,168.8129 shares of common stock, which include 5.1019 shares acquired on June 12, 2026 under a dividend reinvestment plan and 107 shares acquired on June 30, 2026 under an employee stock purchase plan. He also held 821.7371 shares indirectly through an ESOP trustee and 941.2140 shares indirectly through an IRA.
Hawkins, Inc. reported a board-level change. On August 13, 2026, director Yi “Faith” Tang notified the company of her resignation from its Board of Directors and its committees, effective immediately. The company states that her resignation is not due to any disagreement relating to its operations, policies or practices.
The report is filed under the Exchange Act as a current report, with Hawkins, Inc. identified as a Minnesota corporation whose common stock trades on The Nasdaq Stock Market LLC under the symbol HWKN. The filing is signed by Daniel A. Louismet, Vice President, General Counsel and Secretary, on August 14, 2026.
Hawkins Inc. CEO and President Patrick H. Hawkins reported a bona fide gift of 580 shares of common stock on August 7, 2026, made for no consideration. After this disposition, he directly holds 321,257.0494 shares, which include 4.1891 shares from a dividend reinvestment plan and 107 shares from an employee stock purchase plan, and indirectly holds 26,084.9395 shares through an ESOP trustee.
State Street Corporation reported a passive ownership stake in Hawkins Inc. common stock. State Street and its investment advisory subsidiaries beneficially owned 1,061,843 shares of Hawkins, representing 5.1% of the outstanding common stock as of the reported date.
The group reported no sole voting or dispositive power, with 998,659 shares subject to shared voting power and 1,061,843 shares subject to shared dispositive power. The holdings are managed through entities including SSGA Funds Management, Inc. and various State Street Global Advisors affiliates, indicating institutional, advisory control on behalf of underlying clients rather than proprietary ownership.
Hawkins, Inc. reported the results of its July 29, 2026 annual meeting of shareholders. All eight director nominees were elected; for votes ranged from 14,691,318 for James A. Faulconbridge to 16,051,888 for Jeffrey E. Spethmann, with additional withheld and broker non-vote shares recorded.
Shareholders also ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending March 28, 2027, with 18,091,616 votes for, 106,215 against and 39,264 abstentions. On a non-binding advisory basis, shareholders approved executive compensation with 15,626,644 votes for, 450,896 against, 15,963 abstentions and 2,143,592 broker non-votes.
Hawkins Inc director Mary J. Schumacher received a grant of 721 shares of common stock on 2026-07-29 at a stated price of $0.0000 per share, described as a grant or award acquisition. Following this award, her directly held position increased to 26,898 common shares.
The transaction was reported as an acquisition rather than a market purchase or sale and was not indicated as made under a Rule 10b5-1 trading plan.
Faulconbridge James A reported acquisition or exercise transactions in this Form 4 filing.
Hawkins Inc director James A. Faulconbridge received an award of 721 shares of Common Stock on 2026-07-29. The shares were reported at a per-share value of $0.0000, indicating a grant or award rather than a market purchase. Following this transaction, he directly owns 53,128 shares of Hawkins Inc Common Stock.